BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19766068)

  • 1. Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus.
    Esfandyari T; Tefferi A; Szmidt A; Alain T; Zwolak P; Lasho T; Lee PW; Farassati F
    Mol Oncol; 2009 Dec; 3(5-6):464-8. PubMed ID: 19766068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
    Farassati F; Pan W; Yamoutpour F; Henke S; Piedra M; Frahm S; Al-Tawil S; Mangrum WI; Parada LF; Rabkin SD; Martuza RL; Kurtz A
    Am J Pathol; 2008 Dec; 173(6):1861-72. PubMed ID: 18988803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity.
    Cuddington BP; Mossman KL
    J Virol; 2014 Jun; 88(12):6885-95. PubMed ID: 24696490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1.
    Pan W; Bodempudi V; Esfandyari T; Farassati F
    PLoS One; 2009 Aug; 4(8):e6514. PubMed ID: 19652721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.
    Farassati F; Yang AD; Lee PW
    Nat Cell Biol; 2001 Aug; 3(8):745-50. PubMed ID: 11483960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras.
    Deora AA; Hajjar DP; Lander HM
    Biochemistry; 2000 Aug; 39(32):9901-8. PubMed ID: 10933809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.
    Ng MH; Ng RK; Kong CT; Jin DY; Chan LC
    Exp Hematol; 2010 Jun; 38(6):481-8. PubMed ID: 20362031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.
    Shirota T; Kasuya H; Kodera Y; Nishikawa Y; Shikano T; Sahin TT; Gewen T; Yamamura K; Fukuda S; Kanzaki A; Yamada S; Fujii T; Sugimoto H; Nomoto S; Takeda S; Nakao A
    Hepatogastroenterology; 2011; 58(110-111):1482-9. PubMed ID: 21940320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.
    Borrego-Diaz E; Mathew R; Hawkinson D; Esfandyari T; Liu Z; Lee PW; Farassati F
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1742-9. PubMed ID: 21740363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway.
    Sarinella F; Calistri A; Sette P; Palù G; Parolin C
    Gene Ther; 2006 Jul; 13(14):1080-7. PubMed ID: 16554839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Ca
    Duran P; Sandoval A; González-Ramírez R; Zarco N; Felix R
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E232-E244. PubMed ID: 32369417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gi proteins use a novel beta gamma- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes.
    Hedin KE; Bell MP; Huntoon CJ; Karnitz LM; McKean DJ
    J Biol Chem; 1999 Jul; 274(28):19992-20001. PubMed ID: 10391949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy.
    Fox CR; Parks GD
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
    Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
    Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells.
    Fasullo M; Burch AD; Britton A
    Cell Cycle; 2009 Jul; 8(14):2194-7. PubMed ID: 19502787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation.
    Stewart S; Guan KL
    J Biol Chem; 2000 Mar; 275(12):8854-62. PubMed ID: 10722731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells.
    Schneider H; Wang H; Raab M; Valk E; Smith X; Lovatt M; Wu Z; Maqueira-Iglesias B; Strebhardt K; Rudd CE
    PLoS One; 2008 Mar; 3(3):e1718. PubMed ID: 18320039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.